Sino Biopharmaceutic (SBMFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 3,426,483 | 3,506,664 | 3,156,265 | 0 | 2,038,791 |
| Cost of Goods | 750,918 | 712,831 | 634,156 | N/A | N/A |
| Gross Profit | 2,675,565 | 2,793,833 | 2,522,109 | N/A | 2,038,791 |
| Operating Expenses | 1,902,768 | 1,969,529 | 781,225 | 0 | 0 |
| Operating Income | 773,714 | 825,135 | 1,741,040 | N/A | 2,038,791 |
| Interest Expense | 46,856 | 33,274 | 23,158 | 0 | 0 |
| Other Income | -468 | 16,118 | 9,052 | 0 | 0 |
| Pre-tax Income | 726,390 | 807,979 | 1,726,934 | 0 | 2,038,791 |
| Income Tax | 97,427 | 128,703 | 105,201 | N/A | N/A |
| Net Income Continuous | 628,963 | 679,276 | 1,621,733 | N/A | 246,487 |
| Minority Interests | 227,432 | 287,603 | 254,830 | N/A | N/A |
| Net Income | $401,530 | $391,673 | $1,366,903 | $N/A | $246,487 |
| EPS Basic Total Ops | 0.02 | 0.02 | 0.07 | N/A | 0.01 |
| EPS Basic Continuous Ops | 0.03 | 0.04 | 0.09 | N/A | 0.01 |
| EPS Diluted Total Ops | 0.02 | 0.02 | 0.07 | N/A | 0.01 |
| EPS Diluted Continuous Ops | 0.03 | 0.04 | 0.09 | N/A | 0.01 |
| EPS Diluted Before Non-Recurring Items | 0.02 | N/A | N/A | N/A | 0.01 |
| EBITDA(a) | $1,002,662 | $1,037,270 | $1,918,752 | $N/A | $2,038,791 |